Nevro to Present at Truist Securities MedTech Conference

REDWOOD CITY, Calif., June 11, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic p

PR Newswire04:15

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Nevro Corp. NVRO is well-poised for growth in the coming quarters, courtesy of its research and development (R&D) edge.

Yahoo FinanceJun 5 00:37

Here's Why Nevro Corp. (NVRO) Shares Detracted From Performance

Yahoo FinanceJun 3 16:13

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic...

PR NewswireMay 25 04:15

Nevro Grantd Inducement Restricted Stk Unit Awards Covering 59,460 Common Shrs to 26 New Non-Executive Employees >NVRO

Nevro Grantd Inducement Restricted Stk Unit Awards Covering 59,460 Common Shrs to 26 New Non-Executive Employees >NVRO

Dow JonesMay 25 04:15

Citi Downgrades Nevro(NVRO.US) to Sell Rating, Cuts Target Price to $9

Citi analyst Joanne Wuensch downgrades $Nevro(NVRO.US)$ to a sell rating, and adjusts the target price from $16 to $9.According to TipRanks data, the analyst has a success rate of 62.2% and a total av

Futu NewsMay 23 17:34